Check out my latest article: Aspirin or P2Y12 Inhibitor Monotherapy in Atherosclerotic Cardiovascular Disease: A Clinical Update https://t.co/7g15ARxq70 via @LinkedIn

An exceptional session bringing together distinguished experts in cardiology—certainly not to be missed!

Can #AI_ECG improve #STEMI activation pathways? Check out this interview with @RobertHermanMD discussing their #TCT2025 presentation and #JACCINT simultaneous publication👇🏽 https://t.co/DNbUNiijQt #CardioX #ACCFIT @JACCJournals @smithECGBlog

🚨 #AI-based #ECG analysis significantly improved #STEMI detection, reduced false activations, and enhanced recognition of non-conventional presentations. This supports integration of AI-based ECG analysis into acute chest pain pathways. https://t.co/SZpTwTSfO2 #TCT2025 #JACCINT

Clopidogrel monotherapy is superior to aspirin monotherapy for prevention of MACCE without increasing major bleeding risk & supports the use of clopidogrel over aspirin for secondary prevention in patients with #cvCAD. Learn more: https://t.co/e4yhyqiIbT #CardioX

The First-in-human experience with yet another application for transcatheter electrosurgery ⚡️: SESAME to treat subaortic membrane in 7 patients! At 30-days ✅ NYHA class 1 in all patients ✅ sustained reduction in LVOT gradients ✅ no death, stroke, MI, structural

اللهم إني فوضت أمري إليك وتوكلت عليك فكن لي خير وكيل ودبر لي أمري فإني لا أُحسِن التدبير يا حي يا قيوم برحمتك أستغيث اللهم أصلح لي شأني كله ولا تكلنى الى نفسى طرفة عين.

وَما نَيلُ المَطالِبِ بِالتَمَنّي وَلَكِن تُؤخَذُ الدُنيا غِلابا وَما اِستَعصى عَلى قَومٍ مَنالٌ إِذا الإِقدامُ كانَ لَهُم رِكابا

New meta-analysis of 17 studies showed that CCTA is associated with higher odds of detecting residual leak (LAA patency) & PDL when compared to TEE, now online in @CircImaging @BryanTanMD @FaizMBaqai @nadeemnimri @DrJCheungEP @BCMHeart @BCMDeptMedicine https://t.co/Xy47u24JSW

Amazing study by @abdarabi and the team, shedding light on primary PCI in AMI-CS and mechanical ventilation. Congratulations on this remarkable work! 👏

Another study from Gulf-Cs registry @HMC_Qatar 🇶🇦 is proudly part of it . We think of RVD only w RCA infarcts. In this study the IRL was RCA only in 33% of pts w RVD. LAD was IRL - 50% @jassimalsuwaidi @GHASCAISHOCK @rashaalbawardy @mirvatalasnag https://t.co/mCeKnwBkGy

AMI-CS is associated with a significantly high mortality risk. A recent study from Heart Hospital @HMC_Qatar showed that pre-hospital shock team activation was associated with improved survival outcomes. Congratulations to the team on this amazing work!

Really wonderful work by our colleagues in Qatar who have amazing STEMI volume. First team to suggest improved outcomes for pre hospital CS team activation. Congratulations @abdarabi @jassimalsuwaidi @AlhijjiM @HMC_Qatar

Great experience at #ACC25 in Chicago! Exciting discussions, groundbreaking research, and valuable connections with colleagues. Looking forward to more! #Cardiology #ACC2025

https://t.co/3Me4igkAyG

اللهم لك الحمد كما ينبغي لجلال وجهك وعظيم سلطانك.

Our work was awarded the 2024 Paul Dudley White International Scholar @AHAScience - Highest ranked abstract #Qatar Uninterrupted SGLT2i use among patients undergoing PCI doesn't increase CIN. https://t.co/Qt0NneiuaT @abdarabi @American_Heart @MohanadShehadeh

ICD implantation among LVAD recipients showed similar mortality compared to no ICD. #ESCCongress2024 @aomar4646

Indications of SGLT2is keep expanding ...

We judge the success of thrombolysis in STEMI ST resolution , but what happens if there is no STE resolution post PPCI . A study from our center presented at TCTAP showed : Lack of ST resolution post PPCI is common and associated with > 4 folds increase in mortality and HF #pci